KinoPharma, Inc.
PrivateLast Round
Corporate Funding
Apr 25, 2025
Total Funding Raised
$320,000
Company Overview
KinoPharma, Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Corporate Funding round in April 2025.
KinoPharma, Inc. is a clinical-stage biopharmaceutical company that researches and develops small-molecule drugs for viral infections and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KinoPharma, Inc. Comparables
Compare KinoPharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmasum Therapeutics | 74% | |
| Alivexis, Inc. | 72% | |
| Senhwa Biosciences, Inc. | 70% |
For institutional investors. Book with your work email.
KinoPharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 25, 2025 | ||||
| Corporate Funding | Dec 25, 2024 | ||||
| VC Round | Jul 31, 2023 | ||||
| Corporate Funding | Oct 14, 2022 | ||||
| Series D | Dec 15, 2021 | ||||
Corporate Funding | Jan 13, 2021 |
For institutional investors. Book with your work email.
KinoPharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Growth Investment Alliance | VC Round |
| QB Capital | VC Round |
| NCB Venture Capital | VC Round |
| 阿波銀キャピタル株式会社 | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors grew 41% MoM, reaching 1.2K.
- Dec 25, 2024
$320K raised from 阿波銀キャピタル株式会社.
For institutional investors. Book with your work email.
KinoPharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about KinoPharma, Inc.'s valuation, stock price, and market status.
Is KinoPharma, Inc. a public or private company?
KinoPharma, Inc. is a private company.
What is the current stock price of KinoPharma, Inc.?
KinoPharma, Inc. is a private company, so its shares have no public market price. Caplight tracks KinoPharma, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is KinoPharma, Inc. worth (valuation)?
Valuation information for KinoPharma, Inc. is not publicly available.
Can I buy KinoPharma, Inc. stock?
KinoPharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was KinoPharma, Inc.'s last funding round?
KinoPharma, Inc.'s most recent funding round was Corporate Funding on April 25, 2025.
Who are the main investors in KinoPharma, Inc.?
Key investors in KinoPharma, Inc. include Japan Growth Investment Alliance.
Will KinoPharma, Inc. IPO soon?
No public IPO plans have been announced for KinoPharma, Inc..
How can I track KinoPharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in KinoPharma, Inc.'s shares on secondary markets.